ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683628 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683628; 2) Community: the network communities that were significantly associated with the response to NSC 683628; 3) Molecule: the relationships between components within communities and NSC 683628; 4) MDR: the compounds that were significantly associated with the NSC 683628.

NSC Compound Enrichment Correlation
NSC 700906 [1-Methyl-4-[1-methyl-4-(3-methoxysulfonyl)propanamido]pyrole-2-carboxamido]propane 0.0392716453377535 -0.11195458
NSC 717468 Null 0.0392716453377535 -0.044225345
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 0.022966127
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0392716453377535 0.15854096
NSC 725098 Null 0.0392716453377535 0.075111896
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.03246466
NSC 726578 Null 0.0392716453377535 0.0093220423
NSC 727113 Null 0.0392716453377535 0.32068227
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0392716453377535 -0.22926139
NSC 734561 6-(3-chloropropyl)-6,11-dihydro-2,3-dimethoxy-5,11-dioxo-5H- indeno[1,2-c]isoquinoline-9-carbonitrile 0.0392716453377535 0.10245384
Total:120  Current:103    [First] [Prev] [Next] [Last]